Related Experiment Video
Updated: Jun 19, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Advances in Apolipoprotein-A4 Biosensing Assays for Depression Diagnosis
Zahra Jamalizadeh Bahaabadi1, Sercan Karav2, Amirhossein Sahebkar3,4,5
1Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
None:
Apolipoprotein-A4 (Apo-A4) is a plasma protein that plays a role in various physiological and behavioral-emotional reactions when faced with stress. Studies have shown a close relationship between Apo-A4 and the onset of depression and its symptoms. However, there is currently no reliable laboratory approach to confirm the diagnosis of depression. Therefore, the development of a precise and effective technique to assess Apo-A4 might help in the early detection and screening of depression and other related psychiatric diseases, as well as in tracking and managing the course of treatment. As technology advances, biosensors have become quick, accurate, and sensitive tools for personal care and illness diagnosis. Biosensors for measuring and detecting Apo-A4 levels have recently been designed. These studies emphasized the development of accurate and sensitive diagnostic and measurement techniques. This review attempts to give a general overview of the role of Apo-A4 in depression and introduce established biosensors for its detection and measurement.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
07:28Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
Published on: May 19, 2022